Steroid Use in Sepsis-induced Conjugated Hyperbilirubinemia: Report of One Case

English | 正體中文 | 简体中文 | Items with full text/Total items : 45422/58598 (78%)
Visitors : 2550404 Online Users : 240

RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.

Home ‧ Login ‧ Upload ‧ Help ‧ About ‧ Administer

TMUIR > Wan Fang Hospital, Taipei Medical University > Department of Internal Medicine > Periodical Articles > Item 987654321/44748

Please use this identifier to cite or link to this item: http://libir.tmu.edu.tw/handle/987654321/44748

Title:	Steroid Use in Sepsis-induced Conjugated Hyperbilirubinemia: Report of One Case 類固醇用於因敗血症引起的結合型高膽紅素血症：一病例報告
Authors:	Wang,Jinn-Li;Ou,Tsong-Yih;Chen,Chun-Nan;Shen,Ein-Yiao 王錦莉;歐聰億;陳俊男;沈淵瑤
Keywords:	類固醇;高膽紅素血症;敗血症;steroid;hyperbilirubinemia;sepsis
Date:	2007-06
Issue Date:	2012-01-31 14:32:51 (UTC+8)
Abstract:	我們報告一個病例，一個女孩本身為急性淋巴球性白血病的病童，因葛蘭氏陰性菌（大腸桿菌）敗血症引起嚴重的結合型高膽紅素血症（全部膽紅素34.32mg/dl，直接型26.94mg/dl）。此病童接受靜脈內廣泛性抗生素治療，但膽紅素仍持續上升。當她出現意識模糊，倦怠和遲鈍的情形時，我們給予類固醇輔助治療(Hydrocortisone 8mg/kg/day)，而後黃疸和意識狀態很快就恢復了。基於上述發現，我們認為高劑量類固醇有助於輔助治療因葛蘭氏陰性菌敗血症引成的結合型高膽紅素血症。 We report a girl with acute lymphoblastic leukemia who developed severe conjugated hyperbilirubinemia (total bilirubin 34.32 mg/dl, direct bilirubin 26.94 mg/dl) following gram-negative (Escherichia coli) sepsis. Despite broad-spectrum antibiotics, her hyperbilirubinemia progressed. Her mental status deteriorated and steroid therapy (hydrocortisone 8 mg/kg/d) was initiated. Her condition then recovered rapidly. Based on our findings, we suggest that steroid may help to treat progressive conjugated hyperbilirubinemia due to gram-negative sepsis.
Relation:	Acta Paediatrica Taiwanica. 48(3): 146-148
Appears in Collections:	[Department of Internal Medicine] Periodical Articles

Files in This Item:

File	Size	Format
Steroid Use in Sepsis-induced Conjugated Hyperbilirubinemia: Report of One Case	0Kb	HTML	265	View/Open

著作權聲明 Copyright Notice

本平台之數位內容為臺北醫學大學所收錄之機構典藏，包含體系內各式學術著作及學術產出。秉持開放取用的精神，提供使用者進行資料檢索、下載與取用，惟仍請適度、合理地於合法範圍內使用本平台之內容，以尊重著作權人之權益。商業上之利用，請先取得著作權人之授權。
The digital content on this platform is part of the Taipei Medical University Institutional Repository, featuring various academic works and outputs from the institution. It offers free access to academic research and public education for non-commercial use. Please use the content appropriately and within legal boundaries to respect copyright owners' rights. For commercial use, please obtain prior authorization from the copyright owner.
瀏覽或使用本平台，視同使用者已完全接受並瞭解聲明中所有規範、中華民國相關法規、一切國際網路規定及使用慣例，並不得為任何不法目的使用TMUIR。
By utilising the platform, users are deemed to have fully accepted and understood all the regulations set out in the statement, relevant laws of the Republic of China, all international internet regulations, and usage conventions. Furthermore, users must not use TMUIR for any illegal purposes.
本平台盡力防止侵害著作權人之權益。若發現本平台之數位內容有侵害著作權人權益情事者，煩請權利人通知本平台維護人員([email protected])，將立即採取移除該數位著作等補救措施。
TMUIR is made to protect the interests of copyright owners. If you believe that any material on the website infringes copyright, please contact our staff([email protected]). We will remove the work from the repository.

Loading...